• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination Survey.韩国丙型肝炎病毒感染的流行率、知晓率和治疗率:来自韩国国家健康和营养检查调查的证据。
Gut Liver. 2020 Sep 15;14(5):644-651. doi: 10.5009/gnl19272.
2
Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea.朝鲜脱北者丙型肝炎病毒感染血清流行率调查。
J Korean Med Sci. 2023 Aug 28;38(34):e270. doi: 10.3346/jkms.2023.38.e270.
3
Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.2010年美国各州及哥伦比亚特区丙型肝炎病毒感染的州级患病率估计
Clin Infect Dis. 2017 Jun 1;64(11):1573-1581. doi: 10.1093/cid/cix202.
4
A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea.韩国普通人群丙型肝炎知识知晓率和检测率调查
Gut Liver. 2020 Nov 15;14(6):808-816. doi: 10.5009/gnl19296.
5
The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015.2009 年至 2015 年韩国全国丙型肝炎病毒血清流行率变化及与护理的关联状况。
Hepatol Int. 2019 Sep;13(5):599-608. doi: 10.1007/s12072-019-09975-y. Epub 2019 Aug 20.
6
A nationwide seroepidemiology of hepatitis C virus infection in South Korea.韩国全国丙型肝炎病毒感染的血清流行病学研究。
Liver Int. 2013 Apr;33(4):586-94. doi: 10.1111/liv.12108. Epub 2013 Jan 29.
7
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.1999年至2002年美国丙型肝炎病毒感染的流行情况。
Ann Intern Med. 2006 May 16;144(10):705-14. doi: 10.7326/0003-4819-144-10-200605160-00004.
8
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.美国慢性丙型肝炎病毒感染,2003 年至 2010 年全国健康和营养调查。
Ann Intern Med. 2014 Mar 4;160(5):293-300. doi: 10.7326/M13-1133.
9
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.1988年至1994年美国丙型肝炎病毒感染的流行情况。
N Engl J Med. 1999 Aug 19;341(8):556-62. doi: 10.1056/NEJM199908193410802.
10
The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.美国丙型肝炎病毒感染的流行趋势变化:2001 年至 2010 年全国健康和营养调查。
J Hepatol. 2014 Apr;60(4):691-8. doi: 10.1016/j.jhep.2013.11.014. Epub 2013 Nov 27.

引用本文的文献

1
A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles.一份关于丙型肝炎消除的国家政策、计划及进展的2024年全球报告:来自33份肝炎消除概况的调查结果
Lancet Gastroenterol Hepatol. 2025 Jul;10(7):685-700. doi: 10.1016/S2468-1253(25)00068-8. Epub 2025 May 20.
2
Temporal and geospatial patterns of hepatitis C virus prevalence: a longitudinal examination using national health insurance service data in the Republic of Korea (2005-2022).丙型肝炎病毒流行的时间和地理空间模式:利用大韩民国国家健康保险服务数据进行的纵向研究(2005 - 2022年)
BMC Public Health. 2025 Apr 3;25(1):1248. doi: 10.1186/s12889-025-21777-6.
3
Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea: Editorial on "Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness".全民自我检测作为韩国消除丙型肝炎病毒的一种经济高效手段:关于《按照世界卫生组织目标消除丙型肝炎的自我检测策略:疾病负担与成本效益分析》的社论
Clin Mol Hepatol. 2025 Apr;31(2):596-598. doi: 10.3350/cmh.2024.0992. Epub 2024 Nov 11.
4
Correspondence to letter to the editor on "Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults".致编辑的信,内容为“2012年至2022年韩国成年人对病毒性肝炎的当代认知”
Clin Mol Hepatol. 2025 Apr;31(2):e149-e151. doi: 10.3350/cmh.2024.0944. Epub 2024 Nov 6.
5
Awareness of Hepatitis C Among the General Population of Riyadh, KSA, in 2023: A Cross-Sectional Study.2023年沙特阿拉伯利雅得普通人群丙型肝炎知晓情况:一项横断面研究
Cureus. 2024 Jan 7;16(1):e51783. doi: 10.7759/cureus.51783. eCollection 2024 Jan.
6
Hepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012-2022: A Multicenter, Retrospective Study.2012-2022 年韩国注射吸毒者丙型肝炎病毒血清流行率:一项多中心回顾性研究。
J Korean Med Sci. 2023 Dec 11;38(48):e357. doi: 10.3346/jkms.2023.38.e357.
7
Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study.韩国消除乙型和丙型肝炎病毒感染的核心指标:一项全国性研究。
Clin Mol Hepatol. 2023 Jul;29(3):779-793. doi: 10.3350/cmh.2023.0110. Epub 2023 May 15.
8
The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection.丙型肝炎病毒抗体水平对慢性丙型肝炎病毒感染的诊断意义。
Korean J Intern Med. 2023 May;38(3):362-371. doi: 10.3904/kjim.2022.350. Epub 2023 Apr 11.
9
Next-generation sequencing analysis of hepatitis C virus resistance-associated substitutions in direct-acting antiviral failure in South Korea.韩国直接作用抗病毒药物失败中丙型肝炎病毒耐药相关替换的下一代测序分析。
Clin Mol Hepatol. 2023 Apr;29(2):496-509. doi: 10.3350/cmh.2022.0345. Epub 2023 Mar 6.
10
The Incidence and Care Cascade of the Hepatitis C Virus in Korea.韩国丙型肝炎病毒的发病和护理级联。
Gut Liver. 2023 Nov 15;17(6):926-932. doi: 10.5009/gnl220322. Epub 2023 Mar 2.

本文引用的文献

1
Corrigendum to 'EASL recommendations on treatment of hepatitis C: Final update of the series [J Hepatol 73 (2020) 1170-1218].《欧洲肝脏研究学会丙型肝炎治疗推荐:系列最终更新版》勘误 [《肝脏病学杂志》73卷(2020年)1170 - 1218页]
J Hepatol. 2023 Feb;78(2):452. doi: 10.1016/j.jhep.2022.10.006. Epub 2022 Dec 1.
2
Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey.美国慢性病毒性肝炎认知情况:国家健康和营养调查更新。
J Viral Hepat. 2019 May;26(5):596-602. doi: 10.1111/jvh.13060. Epub 2019 Mar 13.
3
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.估计 2013-2016 年美国丙型肝炎病毒感染的流行率。
Hepatology. 2019 Mar;69(3):1020-1031. doi: 10.1002/hep.30297. Epub 2018 Nov 6.
4
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.2018 年丙型肝炎治疗指南更新:美国肝病研究学会-美国传染病学会丙型肝炎病毒感染检测、管理和治疗推荐意见。
Clin Infect Dis. 2018 Oct 30;67(10):1477-1492. doi: 10.1093/cid/ciy585.
5
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.丙型肝炎:欧洲及各国在欧洲消除丙型肝炎病毒成功战略的关键要素之初探
J Viral Hepat. 2018 Mar;25 Suppl 1:6-17. doi: 10.1111/jvh.12875.
6
Assessing hepatitis C spontaneous clearance and understanding associated factors-A systematic review and meta-analysis.评估丙型肝炎的自发清除率并了解相关因素——一项系统评价和荟萃分析
J Viral Hepat. 2018 Jun;25(6):680-698. doi: 10.1111/jvh.12866. Epub 2018 Mar 13.
7
Socioeconomic differences in self- and family awareness of viral hepatitis status among carriers of hepatitis B or C in rural Korea.韩国农村地区乙型或丙型肝炎病毒携带者的自我和家庭对病毒性肝炎状况的认知在社会经济方面存在差异。
Am J Infect Control. 2018 Mar;46(3):328-332. doi: 10.1016/j.ajic.2017.09.001. Epub 2017 Nov 3.
8
Current status and strategies for hepatitis B control in Korea.韩国乙型肝炎防治的现状与策略。
Clin Mol Hepatol. 2017 Sep;23(3):205-211. doi: 10.3350/cmh.2017.0104. Epub 2017 Sep 19.
9
Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims' Data.2009 年至 2013 年韩国慢性丙型肝炎的医疗费用:国家健康保险索赔数据的分析。
Gut Liver. 2017 Nov 15;11(6):835-842. doi: 10.5009/gnl17034.
10
Prevalence of false-positive hepatitis C antibody results, National Health and Nutrition Examination Study (NHANES) 2007-2012.2007 - 2012年美国国家健康与营养检查调查(NHANES)中丙型肝炎抗体假阳性结果的患病率
J Clin Virol. 2017 Apr;89:1-4. doi: 10.1016/j.jcv.2017.01.007. Epub 2017 Jan 30.

韩国丙型肝炎病毒感染的流行率、知晓率和治疗率:来自韩国国家健康和营养检查调查的证据。

Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination Survey.

机构信息

Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.

出版信息

Gut Liver. 2020 Sep 15;14(5):644-651. doi: 10.5009/gnl19272.

DOI:10.5009/gnl19272
PMID:31842525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7492487/
Abstract

BACKGROUND/AIMS: This study aimed to investigate the epidemiology of hepatitis C virus (HCV) infection in the Korean general population and the awareness and treatment status of HCV infection among anti-HCV-positive persons.

METHODS

We used data from the Korea National Health and Nutrition Examination Survey (KNHNES) collected between 2012 and 2016. All the participants aged ≥10 years in the KNHNES were tested for the anti-HCV antibody. Anti-HCV-positive persons were tested for HCV RNA and assessed for their awareness and treatment experience regarding HCV infection.

RESULTS

The prevalence of anti-HCV was 0.66% (95% confidence interval, 0.56% to 0.78%) among Koreans aged ≥10 years, representing an estimated 278,819 anti-HCV-positive persons, and 0.71% (95% confidence interval, 0.60% to 0.84%) among Koreans aged ≥20 years. The prevalence of anti-HCV increased with age and had significant geographic variation. The positive rate of HCV RNA in anti-HCV-positive persons was 33.5% and increased with age. The rate of HCV infection awareness was 15.2% (35/250) among anti- HCV-positive persons and 30.5% (18/59) among HCV RNApositive persons. Among the participants, 13.5% of HCV RNA-positive persons had been treated for HCV infection.

CONCLUSIONS

The prevalence of anti-HCV among Koreans aged ≥20 years was 0.71%; one-third of anti-HCV-positive persons tested HCV RNA-positive. The awareness and treatment rates of HCV infection were low among HCV-infected persons. Therefore, active measures should be taken to diagnose and treat persons unaware of HCV infection.

摘要

背景/目的:本研究旨在调查韩国普通人群中丙型肝炎病毒(HCV)感染的流行病学情况,以及抗-HCV 阳性者对 HCV 感染的知晓和治疗状况。

方法

我们使用了 2012 年至 2016 年期间韩国国家健康和营养检查调查(KNHNES)的数据。KNHNES 中所有年龄≥10 岁的参与者都接受了抗-HCV 抗体检测。抗-HCV 阳性者接受了 HCV RNA 检测,并评估了他们对 HCV 感染的知晓和治疗经验。

结果

年龄≥10 岁的韩国人中抗-HCV 的流行率为 0.66%(95%置信区间,0.56%至 0.78%),估计有 278819 名抗-HCV 阳性者,年龄≥20 岁的韩国人中抗-HCV 的流行率为 0.71%(95%置信区间,0.60%至 0.84%)。抗-HCV 的流行率随年龄增长而增加,且具有显著的地域差异。抗-HCV 阳性者中 HCV RNA 的阳性率为 33.5%,并随年龄增长而增加。抗-HCV 阳性者中 HCV 感染的知晓率为 15.2%(35/250),HCV RNA 阳性者中为 30.5%(18/59)。在参与者中,13.5%的 HCV RNA 阳性者接受了 HCV 感染的治疗。

结论

年龄≥20 岁的韩国人中抗-HCV 的流行率为 0.71%;三分之一的抗-HCV 阳性者检测 HCV RNA 阳性。HCV 感染者中 HCV 感染的知晓率和治疗率较低。因此,应采取积极措施诊断和治疗未意识到 HCV 感染的人群。